DrugDashboards

rocuronium bromide

rocuronium bromide · ROCURONIUM BROMIDE 10 mg/mL · Injection, Solution · Intravenous · Hospira, Inc.

NDC 00409-1403-10 · 10 VIAL, MULTI-DOSE in 1 CARTON / 5 mL in 1 VIAL, MULTI-DOSE · ANDA · View full market →

The short version

12 companies supply this market — deep enough that no single failure threatens the supply. The generic price is down 25% over the past year, to $0.3942 per mL. It is in shortage right now — FDA lists the reason as “delay in shipping of the drug”. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Jun 2024Sep 2026$0.3942
9 price points · per ML · held since Invalid DateSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$18.27
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$4,716
787 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

43● Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • in shortage now+25
  • price down 25% year over year+8
  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.4%chance of a new FDA shortage posting for rocuronium bromide (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA205656
TE code
AP
Approval date
Apr 4, 2018
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05)Feb 15, 2023
    Delay in shipping of the drug
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05)Feb 15, 2023
    Delay in shipping of the drug
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months
  • In shortage now — Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05)Feb 15, 2023
    month 43 — 2× the typical 20-month injectable shortage · model puts 31% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of rocuronium bromide (Injection, Solution)

LabelerStrengthFirst seenLast seen
BE Pharmaceuticals Inc.ROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Caplin Steriles LimitedROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.ROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
ProPharma DistributionROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCROCURONIUM BROMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026
Eugia US LLCROCURONIUM BROMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstROCURONIUM BROMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstROCURONIUM BROMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
Phlow CorporationROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Sandoz IncROCURONIUM BROMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Shandong New Time Pharmaceutical Co., Ltd.ROCURONIUM BROMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
Shandong New Time Pharmaceutical Co., Ltd.ROCURONIUM BROMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026
Steriscience Specialties Private LimitedROCURONIUM BROMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "rocuronium bromide — NDC 00409-1403-10," retrieved September 3, 2026, https://drugdashboards.com/drug/00409140310.

Free to cite with attribution — see how the data is put together.